Document Detail

LOX-1: A Critical Player in the Genesis and Progression of Myocardial Ischemia.
MedLine Citation:
PMID:  21847544     Owner:  NLM     Status:  Publisher    
Myocardial ischemia is the most common cause of mortality and morbidity in the developed countries and rapidly becoming a common malady in the developing countries. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), encoded by the OLR1 gene, is a scavenger receptor that plays a fundamental role in the genesis and progression of atherosclerosis and its complications. LOX-1 has been identified as a major receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial cells, cardiomyocytes and fibroblast. In vitro and in vivo studies show that LOX-1 is upregulated during acute myocardial ischemia, and continues to be upregulated during chronic ischemia. Further, LOX-1 inhibition reduces ischemic myocardial injury and limits cardiac remodeling. LOX-1 inhibition decreases oxidative stress and inflammatory response to injury resulting in limitation of ischemic injury. Molecular studies show that LOX-1 inhibition reduces release of pro-inflammatory cytokines and expression of angiotensin II type 1 receptor via inhibition of redox-sensitive pathways. These alterations limit cardiomyocyte hypertrophy and collagen accumulation in the ischemic regions. These alterations in molecular signaling and physical alterations can result in improved cardiac function and better survival after ischemic myocardial injury.
Jingjun Lü; Jawahar L Mehta
Related Documents :
16531114 - Heart failure and chronic obstructive pulmonary disease: an ignored combination?
20515854 - Detailed electrical analysis of lead failures in a small-scaled right ventricular defib...
3813644 - Tachycardia and heart failure after ritual circumcision.
24492744 - Bayesian analysis of perfusion-weighted imaging to predict infarct volume: comparison w...
9366284 - Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
10088074 - Subacute left ventricular free-wall rupture in early course of acute myocardial infarct...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-17
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  -     ISSN:  1573-7241     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Emergency Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China, 430060,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synovial Tissue Heterogeneity and Peripheral Blood Biomarkers.
Next Document:  Comparison between quantitative assessment of bowel wall vascularization by contrast-enhanced ultras...